These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31680775)

  • 1. Expression of potassium channel genes predicts clinical outcome in lung cancer.
    Ko EA; Kim YW; Lee D; Choi J; Kim S; Seo Y; Bang H; Kim JH; Ko JH
    Korean J Physiol Pharmacol; 2019 Nov; 23(6):529-537. PubMed ID: 31680775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion channel gene expression predicts survival in glioma patients.
    Wang R; Gurguis CI; Gu W; Ko EA; Lim I; Bang H; Zhou T; Ko JH
    Sci Rep; 2015 Aug; 5():11593. PubMed ID: 26235283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival.
    Qian Z; Zhou T; Gurguis CI; Xu X; Wen Q; Lv J; Fang F; Hecker L; Cress AE; Natarajan V; Jacobson JR; Zhang DD; Garcia JG; Wang T
    Sci Rep; 2015 Nov; 5():16889. PubMed ID: 26596768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
    Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
    Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA gene signature for identification of lung cancer.
    Xue Z; Wen J; Chu X; Xue X
    Surg Oncol; 2014 Sep; 23(3):126-31. PubMed ID: 25031224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.
    Chang WH; Forde D; Lai AG
    J Transl Med; 2019 Jan; 17(1):14. PubMed ID: 30626396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A six-gene signature predicting breast cancer lung metastasis.
    Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
    Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation.
    Meng L; Xu Y; Xu C; Zhang W
    Onco Targets Ther; 2016; 9():6177-6185. PubMed ID: 27785066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.
    Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ
    Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
    Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
    Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and functions from breast cancer signatures.
    Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
    Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
    Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
    Georgescu C; Corbin JM; Thibivilliers S; Webb ZD; Zhao YD; Koster J; Fung KM; Asch AS; Wren JD; Ruiz-Echevarría MJ
    BMC Cancer; 2019 May; 19(1):423. PubMed ID: 31060542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.
    Seike M; Yanaihara N; Bowman ED; Zanetti KA; Budhu A; Kumamoto K; Mechanic LE; Matsumoto S; Yokota J; Shibata T; Sugimura H; Gemma A; Kudoh S; Wang XW; Harris CC
    J Natl Cancer Inst; 2007 Aug; 99(16):1257-69. PubMed ID: 17686824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
    Wen Q; Kim CS; Hamilton PW; Zhang SD
    BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.